Navigation Links
Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
Date:2/13/2008

FRAZER, Pa., Feb. 13 /PRNewswire-FirstCall/ -- Cephalon, Inc., (Nasdaq: CEPH) issued the following statement in response to a complaint filed today by the U.S. Federal Trade Commission (FTC) in U.S. District Court for the District of Columbia challenging the validity of certain agreements entered into by the company in late 2005 and early 2006 to settle the PROVIGIL(R) (modafinil) [C-IV] patent infringement litigation and seeking to permanently enjoin the Company from maintaining or enforcing these agreements.

Cephalon stands by the strength and validity of our PROVIGIL patents and the legal basis for these settlements. We are disappointed that the FTC has determined to challenge these agreements as we believe they fully comply with both the spirit and letter of the antitrust laws. As importantly, our settlements confer a meaningful benefit to U.S. consumers by providing for the entry of generic modafinil three years early.

Cephalon is prepared to vigorously defend itself in this matter and expects to prevail.

About Cephalon, Inc.

Founded in 1987, Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. A member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota. The company's European headquarters are located in Maisons-Alfort, France.

The company's proprietary products in the United States include: PROVIGIL, FENTORA(R) (fentanyl buccal tablet) [C-II], TRISENOX(R) (arsenic trioxide) injection, AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules), VIVITROL(R) (naltrexone fo
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cephalons 2007 Results Exceed Full Year Sales and Earnings Guidance
2. Cephalon General Counsel John E. Osborn to Resign Position
3. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
4. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
5. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
6. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Announces Strong Third Quarter Financial Results
9. Cephalon Quarterly Conference Call Invitation
10. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
11. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...APOLIS and NORTH VANCOUVER, British Columbia, Dec.... a wholly owned subsidiary of The Dow Chemical Com.... today announced the signing of a research and co...rovides Dow AgroSciences with access to Agrisoma,s...y on an exclusive basis in major food crops, and o...
(Date:12/1/2009)... DNA Genotek, a leading provider of products... that Tepnel Pharmaceutical Services will offer Or...ts nucleic acid extraction and genotyping service....ember 1, 2009 -- DNA Genotek , a leading provider...ay announced that Tepnel Pharmaceutical Services ...
(Date:12/1/2009)... Michael R. Drapp, a 34-year veteran of the ...e; Technologies, a business development and intell...emerging nanotechnology space. The company also p...s a nanotechnology incubator. , ...ichael R. Drapp , a 34-year veteran of the high-te...
(Date:11/30/2009)...RK, Nov. 30 The Michael... today announced $1.5 million in total awards to s...isease-modifying therapies for Parkinson,s disease...hes to Drug Discovery for Parkinson,s Disease pro...on, plc (NYSE: ELN ), a neuroscience-based biote...
Breaking Biology Technology:Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3
...n. Source: Teresa Esser. Appleton, Wis. The he...to wisconsin recently to encourage angels to band ...preneur in residence at ,the Kauffman Foundation,..., Wisconsin. , ,Preston said that in 2003, U.S. ve...ies of various sizes, but only $354 million was gi...
.... The Academy of Appleton has started to use h...ntry. Children at the Academy wait indoors to be p...h the faculty members, use the biometric HandReade...nt component of the technology allows staff to ent... and weekends. , ,The HandReader, a technology fro...
...oor guy who got his hand stuck in a crevice and ha...like interviewing your 2-year-old nephew: Whats yo...se? This could happen to you, too. You find yourse...mes locked in a corner in the vice grip of a bad,...limb to lop off in order to free yourself. , ,It m...
Other Biology Technology:Susan Preston, entrepreneur, on how to set up angel networks 2Susan Preston, entrepreneur, on how to set up angel networks 3Susan Preston, entrepreneur, on how to set up angel networks 4Susan Preston, entrepreneur, on how to set up angel networks 5Appleton school installs biometric security 2How to get through tech-sector networking events alive 2How to get through tech-sector networking events alive 3How to get through tech-sector networking events alive 4How to get through tech-sector networking events alive 5
(Date:11/30/2009)... team overcame a major hurdle plaguing the develop...d to more efficient catalysts used to produce hydr...chers reported Nov. 29 in Nature Materials the f...n metallic nanoparticles, the vaunted next-generat...me heat. , Gtz Veser, an associate professor and...
(Date:11/30/2009)...U Health Sciences Center New Orleans School of Pub...ute of Child Health and Human Development (NICHD),...n,s Hospital, and Harvard Medical School, have fou...rvings of sugar- sweetened cola a week prior to pr...of developing diabetes during pregnancy. Liwei Che...
(Date:11/30/2009)...imental Biology are pleased to announce that Dr X...Scientifique (CNRS) in the Universit de Nice-Sophi...standing Paper Prize. ,The prize is awarded in rec...nded to encourage young scientists, says Hans Hop...we truly appreciate when authors submit their very...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Perrigo Confirms Filing for Generic Version of Mens Rogaine 28R 29 Foam 5421 1Perrigo Confirms Filing for Generic Version of Mens Rogaine 28R 29 Foam 5421 2Perrigo Confirms Filing for Generic Version of Mens Rogaine 28R 29 Foam 5421 3Transparent Inc to Introduce Cell able a Unique Human Hepatocyte Array to U S Market at ISSX Meeting 5417 1Transparent Inc to Introduce Cell able a Unique Human Hepatocyte Array to U S Market at ISSX Meeting 5417 2Genetics of patterning the cerebral cortex 59356 1Genetics of patterning the cerebral cortex 59356 2Genetics of patterning the cerebral cortex 59356 3
...ir we breathe on a daily basis slowly killing us? ...he and water we drink may be more harmful than we ...nitro-polycyclic aromatic hydrocarbons), both man...ed into the air and are present in food, water sys... Case Western Reserve University chemistry assista...
...N.C. -- A Duke University-led team has brought pow...en antibiotics and germs. Working together, comput...aboratory-tested a computer program that can show ...bacteria use to make natural antibiotics. , The...lgorithm "K*" (pronounced K Star)-- is able to sor...
... Clemson University researchers want to strengthen...and are introducing revolutionary ways for high sc...tudents. , Clemson chemistry professors Melanie C... W. Klymkowsky, a professor in the department of m...e University of Colorado-Boulder, will introduce t...
Other Biology News:Case Western Reserve researchers looking at light-induced toxins in air and water 2Case Western Reserve researchers looking at light-induced toxins in air and water 3Duke software dramatically speeds enzyme design 2Duke software dramatically speeds enzyme design 3Clemson chemists present revolutionary teaching concepts 2
Rabbit Anti-melatonin Antibody, Unconjugated from Cell Sciences
Goat Anti-FbxL7 Polyclonal Antibody, Unconjugated from GeneTex
Rabbit Anti-SERHL Polyclonal Antibody, Unconjugated from Abcam
Sheep Anti-Staphylococcus DNase Polyclonal Antibody, Unconjugated from Abcam
Biology Products: